The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The Microbiota Makes for Good Therapy: The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971 ) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that therapeutic responses may be improved via its modulation (13, 14)”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [14]
In the citing paper
“The P-ESC was considered representative of baseline microbiome data due to observations that the microbiome of patients treated with anti-PD-1, unlike anti-CTLA-4 or chemotherapy, is stable early after therapy initiation17–19.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [19]
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“In addition, broad-spectrum antibiotics (mainly beta-lactams) taken prior to immunotherapy markedly reduce the clinical benefit of ICIs, chimeric antigen receptor (CAR)-T cells, stem cell transplantation in patients, and immunogenic chemotherapy in preclinical tumor models.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [26]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Finally, monoassociation of tumor-bearing GF mice with SFB, which promotes Th17 cell differentiation in the LP (1, 13, 14) also had a detrimental impact on the tumor growthinhibitory effect of CTX (Fig.”
BackgroundImmunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · cited 1×
“Some antineoplastic agents mediate part of their anticancer activity by stimulating anticancer immune responses (6).”
BackgroundSelf-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“S6A) and is required for the therapeutic success of anticancer chemotherapies in several tumor models (19).”
BackgroundSelf-citationInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Self-citation
Research works printed but not linked: 1
- 10.1073/pnas.1113744109 · DOI · Paper page
Cited by
Items 801–900 of 1,012
Scheich, S., Reinheimer, C., Brandt, C., Wichelhaus, T. A., Hogardt, M., Kempf, V. A. J., Brunnberg, U., Brandts, C., Balló, O., von Metzler, I., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.05.016 · Cited by 40
Malard, F., Gaugler, B., & Mohty, M. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00223-x · Cited by 38
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
Kouidhi, S., Zidi, O., Belkhiria, Z., Raïs, H., Ayadi, A., Ayed, F. B., Mosbah, A., Cherif, A., & Gaaied, A. B. A. E. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00132 · Cited by 39
Mousa, S., Sarfraz, M., & Mousa, W. K. (2023) · Metabolites · doi:10.3390/metabo13050674 · Cited by 41
Optimizing Cancer Treatment Through Gut Microbiome Modulation
Kim, K., Lee, M., Shin, Y., Lee, Y., & Kim, T. J. (2025) · Cancers · doi:10.3390/cancers17071252 · Cited by 40
Sharma, P., Kaur, S., Kaur, R., Kaur, M., & Kaur, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00948 · Cited by 38
Le, D. K., Phước, N. N., Nguyen, D., Dierckens, K. R., Boon, N., Lacoere, T., Kerckhof, F., Vrieze, J. D., Vadstein, Ô., & Bossier, P. (2019) · Microbial Ecology · doi:10.1007/s00248-019-01436-1 · Cited by 38
Current understanding of the human microbiome in glioma
Liang, J., Li, T., Zhao, J., Wang, C., & Sun, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.781741 · Cited by 40
The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors
Najafi, S., Majidpoor, J., & Mortezaee, K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121138 · Cited by 38
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 39
Taguer, M., & Maurice, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.366 · Cited by 37
Wolf, K. D., Rottey, S., Vermaelen, K., Decaestecker, K., Sundahl, N., Lobel, L. D., Goetghebeur, E. J. T., Meerleer, G. D., Lumen, N., Fonteyne, V., et al. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0893-x · Cited by 38
Computational methods and challenges in analyzing intratumoral microbiome data
Wang, Q., Liu, Z., Ma, A., Li, Z., Liu, B., & Ma, Q. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.01.011 · Cited by 37
“Sarcoma – Enterococcus hirae s Bacteria [99,100]”
Raman, V., Deshpande, C. P., Khanduja, S., Howell, L. M., Dessel, N. V., & Forbes, N. S. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.006 · Cited by 38
Greil, R., Hutterer, E., Hartmann, T. N., & Pleyer, L. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-016-0155-9 · Cited by 37
A review of immune therapy in cancer and a question: can thermal therapy increase tumor response?
Bull, J. M. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1387938 · Cited by 39
Ziegler, M. J., Han, J., Landsburg, D. J., Pegues, D. A., Reesey, E., Gilmar, C., Gorman, T., Bink, K., Moore, A., & Kelly, B. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz252 · Cited by 39
Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine
Lu, Y., Xie, J., Peng, C., Wang, B., Wang, K., & Li, L. (2018) · Engineering · doi:10.1016/j.eng.2018.11.013 · Cited by 37
Microbiome as an Immunological Modifier
Kumar, M., Singh, P., Murugesan, S., Vétizou, M., McCulloch, J. A., Badger, J. H., Trinchieri, G., & Khodor, S. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_27 · Cited by 40
Huang, J., Zhang, W., Fan, R., Liu, Z., Huang, T., Li, J., Du, T., & Xiong, T. (2020) · Archives of Microbiology · doi:10.1007/s00203-019-01787-w · Cited by 41
Akrami, M., Menzies, R. J., Chamoto, K., Miyajima, M., Suzuki, R., Sato, H., Nishii, A., Tomura, M., Fagarasan, S., & Honjo, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010981117 · Cited by 37
The link among microbiota, epigenetics, and disease development
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13862-1 · Cited by 38
A Perspective on the Role of Microbiome for Colorectal Cancer Treatment
Kalasabail, S., Engelman, J., Zhang, L. Y., El-Omar, E. M., & Yim, H. C. H. (2021) · Cancers · doi:10.3390/cancers13184623 · Cited by 41
The Microbiome in Childhood Acute Lymphoblastic Leukemia
Oldenburg, M., Rüchel, N., Janssen, S., Borkhardt, A., & Gössling, K. L. (2021) · Cancers · doi:10.3390/cancers13194947 · Cited by 41
Umbilical artery acid-base status in the preterm infant.
Ramin, S. M., Gilstrap, L. C., Leveno, K. J., Burris, J., & Little, “. B. B. (1989) · PubMed · Cited by 41
Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Wang, J., Zhu, N., Su, L., & Yang, R. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216582 · Cited by 37
Influence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
The intestinal microbiome and surgical disease
Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 38
Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
Brandi, G., & Frega, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112699 · Cited by 37
The Microbiota in Hematologic Malignancies
Song, Y., Himmel, B., Öhrmalm, L., & Gyarmati, P. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0693-7 · Cited by 38
Liu, Y., & Jiang, H. (2020) · Translational Andrology and Urology · doi:10.21037/tau-20-566 · Cited by 37
Kulkarni, A. A., Ebadi, M., Zhang, S., Meybodi, M. A., Ali, A. M., DeFor, T. E., Shanley, R., Weisdorf, D. J., Ryan, C. J., Vasu, S., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000803 · Cited by 37
Clinical effects and applications of the gut microbiome in hematologic malignancies
D'Angelo, C. R., Sudakaran, S., & Callander, N. S. (2020) · Cancer · doi:10.1002/cncr.33400 · Cited by 36
Sumransub, N., Vantanasiri, K., Prakash, A., & Lou, E. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.05.001 · Cited by 36
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
Rahman, R. A., Lamarca, Á., Hubner, R. A., Valle, J. W., & McNamara, M. G. (2021) · Cancers · doi:10.3390/cancers13153779 · Cited by 36
Enterococcal bacteremia in mice is prevented by oral administration of probiotic Bacillus spores
Piewngam, P., Chiou, J., Ling, J., Liu, R., Pupa, P., Zheng, Y., & Otto, M. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf4692 · Cited by 36
Microbiome influencers of checkpoint blockade–associated toxicity
Wang, Y., Jenq, R. R., Wargo, J. A., & Watowich, S. S. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220948 · Cited by 37
Matsuo, K., Haku, A., Bi, B., Takahashi, H., Kamada, N., Yaguchi, T., Saijo, S., Yoneyama, M., & Goto, Y. (2019) · Microbiology and Immunology · doi:10.1111/1348-0421.12680 · Cited by 38
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 37
Wei, H., Yue, Z., Han, J., Chen, P., Xie, K., Sun, Y., & Zhu, J. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15177 · Cited by 36
Qi, X., Liu, M., Jiang, X., Gao, T., Xu, G., Zhang, H., Su, Q. Y., Du, Y., Luo, J., & Zhang, S. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103912 · Cited by 36
Wang, J., Feng, S., Lin, X., Li, Z., Mao, X., & Jiang, C. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.018 · Cited by 35
Dietary legumes, intestinal microbiota, inflammation and colorectal cancer
Aranda‐Olmedo, I., & Rubio, L. A. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103707 · Cited by 39
Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
He, Y., Lu, M., Che, J., Chu, Q., Zhang, P., & Chen, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.716844 · Cited by 37
Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer
Sarkar, P., Malik, S., Banerjee, A., Datta, C., Pal, D. K., Ghosh, A., & Saha, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.894777 · Cited by 97
Gut microbiota modulate the immune effect against hepatitis B virus infection
Xu, D., Huang, Y., & Wang, J. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2464-0 · Cited by 43
Manfredonia, C., Muraro, M. G., Hirt, C., Mele, V., Governa, V., Papadimitropoulos, A., Däster, S., Soysal, S. D., Droeser, R. A., Mechera, R., et al. (2019) · Advanced Biosystems · doi:10.1002/adbi.201800300 · Cited by 35
Vernaci, G. M., Savarino, E. V., Patuzzi, I., Facchin, S., Zingone, F., Massa, D., Faggioni, G., Giarratano, T., Miglietta, F., Griguolo, G., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad060 · Cited by 36
Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment
Gong, Y., Chen, A., Zhang, G., Shen, Q., Zou, L., Li, J., Miao, Y., & Liu, W. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85259 · Cited by 35
Microbiota as the unifying factor behind the hallmarks of cancer
Benešová, I., Křížová, Ľ., & Kverka, M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05244-6 · Cited by 35
The dual role of autophagy in the regulation of cancer treatment
Kwantwi, L. B. (2024) · Amino Acids · doi:10.1007/s00726-023-03364-4 · Cited by 34
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
Qasem, H., & El-Sayed, W. M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01523-9 · Cited by 34
Zhang, M., Wei, Z., Wei, B., Lai, C., Zong, G., Tao, E., Fan, M., Pan, Y., Zhou, B., Shen, L., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.022 · Cited by 35
Gut Microbiota and the Paradox of Cancer Immunotherapy
Poutahidis, T., Kleinewietfeld, M., & Erdman, S. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00157 · Cited by 34
Zhang, X., Wu, L., Xu, Y., Yu, H. J., Chen, Y., Zhao, H., Lei, J., Zhou, Y. J., Zhang, J., Wang, J., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.03.027 · Cited by 34
Association of the microbiome with colorectal cancer development (Review)
Abdulla, M., Agarwal, D., Singh, J. K., Traiki, T. A. B., Pandey, M. K., Ahmad, R., & Srivastava, S. K. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5197 · Cited by 35
Circulating microbiome DNA: An emerging paradigm for cancer liquid biopsy
Chen, H., Ma, Y., Liu, Z., Li, J., Li, X., Yang, F., & Qiu, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.036 · Cited by 35
Burcher, K. M., Burcher, J. T., Inscore, L., Bloomer, C. H., Furdui, C. M., & Porosnicu, M. (2022) · Cancers · doi:10.3390/cancers14174116 · Cited by 37
Zhang, W., Zhang, Y., Li, Y., Ma, D., Zhang, H., & Kwok, L. Y. (2022) · Nutrients · doi:10.3390/nu15010005 · Cited by 36
The Gut Microbiota in Causation, Detection, and Treatment of Cancer
Murphy, C. L., O’Toole, P. W., & Shanahan, F. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000075 · Cited by 36
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
“[49,57] Efficacies and toxicities of cyclophosphamide,[66,101] gemcitabine,[47] and platinum-based[67,102]”
BackgroundHaberman, Y., Kamer, I., Amir, A., Goldenberg, S., Efroni, G., Daniel‐Meshulam, I., Lobachov, A., Daher, S., Hadar, R., Gantz-Sorotsky, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29136-4 · Cited by 33
Targeting the gut microbiota: a new strategy for colorectal cancer treatment
Hu, Y., Zhou, P., Deng, K., Zhou, Y., & Hu, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05671-0 · Cited by 36
Mycoplasmas and cancer: focus on nucleoside metabolism.
Voorde, J. V., Balzarini, J. M., & Liekens, S. (2014) · EXCLI journal · Cited by 39
Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics
Mussap, M., Loddo, C., Fanni, C., & Fanos, V. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1713750 · Cited by 38
Tao, C., Zhang, Q., Zeng, W., Liu, G., & Shao, H. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10611-1 · Cited by 33
Microbiota modification in hematology: still at the bench or ready for the bedside?
Severyn, C. J., Brewster, R., & Andermann, T. M. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000365 · Cited by 34
Strategies to overcome resistance to immune checkpoint blockade in lung cancer
Attili, I., Tarantino, P., Passaro, A., Stati, V., Curigliano, G., & de Marinis, F. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.02.035 · Cited by 34
Motoori, M., Sugimura, K., Tanaka, K., Shiraishi, O., Kimura, Y., Miyata, H., Yamasaki, M., Makino, T., Miyazaki, Y., Iwama, M., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.03.023 · Cited by 33
Advances in 3D culture systems for therapeutic discovery and development in brain cancer
Wanigasekara, J., Cullen, P. J., Bourke, P., Tiwari, B. K., & Curtin, J. F. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103426 · Cited by 33
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Zhang, J., Xie, Q., Huo, X., Liu, Z., Da, M., Yuan, M., Zhao, Y. D., & Shen, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037831 · Cited by 35
Association between gut microbiota and glioblastoma: a Mendelian randomization study
Wang, S., Yin, F., Guo, Z., Li, R., Sun, W., Wang, Y., Geng, Y., Sun, C., & Sun, D. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2023.1308263 · Cited by 34
The effects of micro RNA on the absorption, distribution, metabolism and excretion of drugs
He, Y., Chevillet, J. R., Liu, G., Kim, T. K., & Wang, K. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12968 · Cited by 37
Galloway-Peña, J. R., Jenq, R. R., & Shelburne, S. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3173 · Cited by 32
Andrews, M. C., Reuben, A., Gopalakrishnan, V., & Wargo, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00946 · Cited by 34
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases
Gonçalves, S. M., Lagrou, K., Duarte-Oliveira, C., Maertens, J. A., Cunha, C., & Carvalho, A. (2017) · Virulence · doi:10.1080/21505594.2016.1257458 · Cited by 32
“composition, the presence (and activity) of the microbiota is, in turn, necessary for the development and function of the immune system.(25,26) When working properly, this immune system-microbiota coalition promotes pro-”
BackgroundZhang, P.-F., & Xie, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362133 · Cited by 39
Jiang, P., Yu, F., Zhou, X., Shi, H., He, Q., & Song, X. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012246 · Cited by 33
Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
Anwer, E. K. E., Ajagbe, M., Sherif, M. A., Musaibah, A. S., Mahmoud, S., ElBanbi, A., & Abdelnaser, A. (2025) · Biomedicines · doi:10.3390/biomedicines13010100 · Cited by 36
Therapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
Self-citationBig Data Approaches for Modeling Response and Resistance to Cancer Drugs
Jiang, P., Sellers, W. R., & Liu, X. S. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013350 · Cited by 35
Role of Microbiome in Modulating Immune Responses in Cancer
Bose, M., & Mukherjee, P. (2019) · Mediators of Inflammation · doi:10.1155/2019/4107917 · Cited by 35
Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway
Lu, P., Xu, M., Xiong, Z., Zhou, F., & Wang, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185766 · Cited by 32
Microbiome and host crosstalk: A new paradigm to cancer therapy
Singh, A. K., Nayak, N., Rathi, P., Verma, D., Sharma, R., Chaudhary, A., Agarwal, A., Tripathi, Y. B., & Garg, N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.014 · Cited by 35
Xu, S., Tan, H., Yang, Q., Wang, R., Tian, C., Ji, Y., Zhao, P., Xia, Q., & Wang, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08409 · Cited by 32
Redrawing therapeutic boundaries: microbiota and cancer
Sholl, J., Sepich‐Poore, G. D., Knight, R. D., & Pradeu, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.008 · Cited by 33
Roles of Microbiota in Cancer: From Tumor Development to Treatment
Bagheri, Z., Moeinzadeh, L., & Razmkhah, M. (2022) · Journal of Oncology · doi:10.1155/2022/3845104 · Cited by 35
Neoadjuvant immunotherapy in gastrointestinal cancers – The new standard of care?
Petričević, B., Kabiljo, J., Zirnbauer, R., Walczak, H., Laengle, J., & Bergmann, M. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.015 · Cited by 32
Xue, L., Li, Z., Xue, J., Wang, H., Wu, T., Liu, R., Sui, W., & Zhang, M. (2022) · Food & Function · doi:10.1039/d1fo04331e · Cited by 33
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Modica, M. D., Arlotta, V., Sfondrini, L., Tagliabue, E., & Triulzi, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947188 · Cited by 36
Wu, A. H., Vigen, C. L. P., Tseng, C.-C., García, A. A., & SPICER, D. V. (2022) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s305486 · Cited by 36
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Wang, L., Tang, L., Zhai, D., Song, M., Li, W., Xu, S., Jiang, S., Meng, H., Liang, J., Wang, Y., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185035 · Cited by 34
Chapadgaonkar, S. S., Bajpai, S., & Godbole, M. S. (2023) · Cancer Reports · doi:10.1002/cnr2.1847 · Cited by 41
Different evasion strategies in multiple myeloma
Wang, C., Wang, W., Wang, M., Deng, J., Sun, C., Hu, Y., & Luo, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346211 · Cited by 34
Altered gut microbiome promotes proteinuria in mice induced by Adriamycin
Jiang, Q., He, X., Zou, Y., Ding, Y., Li, H., & Chen, H. (2018) · AMB Express · doi:10.1186/s13568-018-0558-7 · Cited by 32
Tikka, C., Manthari, R. K., Ommati, M. M., Niu, R., Sun, Z., Zhang, J., & Wang, J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2019.125791 · Cited by 32
Harnessing the microbiome for cancer therapy
Hajjar, R., Mars, R. A. T., & Kashyap, P. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01268-6 · Cited by 34
Moran, C. P., Sheehan, D., & Shanahan, F. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000157 · Cited by 32
Systematic evaluation of immune regulation and modulation
Stroncek, D. F., Butterfield, L. H., Cannarile, M. A., Dhodapkar, M. V., Greten, T. F., Grivel, J., Kaufman, D. R., Kong, H. H., Korangy, F., Lee, P. P., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0223-8 · Cited by 32
Exploring the food-gut axis in immunotherapy response of cancer patients
Russo, E., Nannini, G., Dinu, M., Pagliai, G., Sofi, F., & Amedei, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i33.4919 · Cited by 32
Metadata
- Authors
- Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P.-L., Eberl, G., Bérard, M., Ecobichon, C., Clermont, D., Bizet, C., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Opolon, P., Yessaad, N., Vivier, E., Ryffel, B., Elson, C. O., Doré, J., Kroemer, G., Lepage, P., Boneca, I. G., Ghiringhelli, F., & Zitvogel, L.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Harvard University (US)
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Agency for Science, Technology and Research (SG)
- Institut National de la Santé et de la Recherche Médicale, U866, Centre Georges François Leclerc, Dijon, France.
- Service de Microbiologie, Institut Gustave Roussy, Villejuif, France.
- Institut Gustave Roussy (FR)
- Institut Pasteur (FR)
- Nimalerie Centrale, Institut Pasteur, Paris, France.
- Institut National de la Recherche Agronomique, Micalis–UMR1319, 78350 Jouy-en-Josas, France.
- Centre National de la Recherche Scientifique (FR)
- Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université UM2, Marseille, France.
- Université d'Orléans (FR)
- University of Alabama at Birmingham (US)
- AgroParisTech (FR)
- Corresponding author
- Ghiringhelli, François
- Zitvogel, Laurence
- ORCID
- Mignot, Grégoire
- Yamazaki, Takahiro
- Daillère, Romain
- Hannani, Dalil
- Pfirschke, Christina
- Engblom, Camilla
- Schlitzer, Andreas
- Ginhoux, Florent
- Woerther, Paul-Louis
- Eberl, Gérard
- Clermont, Dominique
- Opolon, Paule
- Ryffel, Bernhard
- Elson, Charles O.
- Kroemer, Guido
- Lepage, Patricia
- Boneca, Ivo Gomperts
- Ghiringhelli, François
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2013-11-22
- Volume
- 342
- Issue
- 6161
- Pages
- 971-976
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4048947
- OpenAlex
- W2059128083
- Cited by
- 2,050
- References
- 43
- Citations by year
- 2026: 109 · 2025: 165 · 2024: 176 · 2023: 216 · 2022: 234 · 2021: 217 · 2020: 220 · 2019: 183 · 2018: 137 · 2017: 116 · 2016: 98 · 2015: 101 · 2014: 69 · 2013: 6
- FWCI
- 40.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- HAL AMU (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-11-PHUC-0002)
- National Cancer Institute (P50CA086355)
- National Institute of Allergy and Infectious Diseases (R01AI084880)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK071176)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- cyclophosphamide, gut microbiota, antitumor immunity, Gram-positive bacteria, Th17 cells, memory T cells, secondary lymphoid organs, bacterial translocation, germ-free mice, antibiotic therapy, adoptive transfer, small intestine
- MeSH terms
- Animals, Anti-Bacterial Agents, Antineoplastic Agents, Cyclophosphamide, Germ-Free Life, Gram-Positive Bacteria, Immunologic Memory, Immunosuppressive Agents, Intestine, Small, Lymphoid Tissue, Neoplasms, Bacterial Translocation, Adoptive Transfer, Mice, Th17 Cells, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.